Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on April 23, 2025

Coave Therapeutics Expands into the US with Strategic Appointment of Romain Pettenaro as VP of Business Development
Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and establish its presence in the Boston biotech hub Paris, France, and Cambridge, MA, USA - April 23, 2025 – Coave Therapeutics (‘Coave’), a …

Upwork Study Finds 1 in 4 U.S. Skilled Knowledge Workers Now Work Independently, Generating $1.5 Trillion in Earnings
PALO ALTO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s work marketplace that connects businesses with independent talent, today unveiled its inaugural Future Workforce Index, a flagship report analyzing the rise of …

Precore Gold Granted Option to Acquire Arikepay Porphyry Gold-Copper Property in Peru
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce that it has entered into a Definitive Option Agreement (the “Option Agreement”) with Alta Copper Corp. ( …

Check Point Software Reports 2025 First Quarter Financial Results
TEL AVIV, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the quarter ended March 31st, 2025. First Quarter 2025 Financial Highlights: Cash Flow from Operations: $ …

Point of Care Hematology Diagnostics Market to Reach $3.0 Bn by 2027 in the short run and $3.6 Bn by 2030 Globally, at 5.8% CAGR: Allied Market Research
Wilmington, Delaware, April 23, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Point of Care Hematology Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2024-2030", valued at $2.4 billion in 2023, is …

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome …

Cytovation Raises US$6m to Advance Phase 2 Development of CY-101 in Adrenocortical Carcinoma to First Clinical Readouts
New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between Cytovation, Cancer Research UK and the Norwegian Cancer Society New preclinical data highlighting potential of CY-101 in ACC …